# DESCRIPTION

## FIELD OF THE DISCLOSURE

- define field of disclosure

## BACKGROUND

- describe bacterial spore coat
- summarize spore formation
- explain coat assembly

## SUMMARY OF THE DISCLOSURE

- summarize particle construct

## DETAILED DESCRIPTION OF SEVERAL EMBODIMENTS

- motivate particle constructs
- advantages of in vitro system

### Terms

- define adjuvant
- describe types of adjuvants
- introduce allergen
- list examples of allergens
- define animal
- introduce antibody
- describe types of antibodies
- explain antibody fragments
- define single-chain antibody
- describe diabodies
- explain binding sites of antibodies
- introduce heavy and light chain variable regions
- describe framework regions and CDRs
- define monoclonal antibody
- introduce chimeric antibody
- define humanized antibody
- describe conservative amino acid substitutions
- introduce antigen
- define anti-infectious agent
- introduce asthma
- define autoimmune disorder
- introduce chemotherapy
- define conservative variants
- define immunogenic composition
- define immunosuppressant
- define infectious agent
- list examples of infectious viruses
- list examples of infectious bacteria
- list examples of infectious fungi
- define isolated
- define mammal
- define nucleic acid
- explain conventional notation for nucleotide sequences
- define recombinant nucleic acid
- define oligonucleotide
- define pharmaceutically acceptable carriers
- describe composition and formulation of carriers
- define polypeptide
- explain preventing or treating a disease
- define reducing a sign or symptom of a disease
- describe prime-boost vaccination
- define sequence identity
- explain methods of alignment for sequence comparison
- define specific binding
- define synthetic
- define therapeutically effective dose
- define tumor
- describe types of tumors
- define under conditions sufficient for and vaccine

### Particle Constructs and Methods of Producing Particle Constructs

- define particle constructs
- describe size of particle constructs
- specify shape of particle constructs
- define average diameter
- describe longest diameter
- explain isolation of particle constructs
- describe storage of particle constructs
- define synthetic core
- specify materials for synthetic core
- describe lipid bilayer coat
- specify lipids for lipid bilayer
- describe anionic and neutral lipids
- specify biodegradable lipids
- describe non-lipid membrane components
- define particle constructs
- describe SpoVM properties
- describe SpoIVA properties
- describe SpoVM-SpoIVA interaction
- describe particle construct formation
- describe reaction conditions
- describe SpoIVA modification
- describe agent delivery
- describe click chemistry application
- introduce particle constructs
- modify SpoIVA with trans-cyclooctene, tetrazine, DBCO, or azide
- describe covalent linking of agent of interest to SpoIVA
- provide non-limiting examples of SpoIVA modification
- describe copper-free click chemistry
- describe copper(I)-catalyzed click chemistry
- list commercially available molecular probes
- outline method for producing particle construct
- define agent of interest
- provide non-limiting examples of agents of interest
- describe immunomodulatory agents
- describe chemokines
- provide non-limiting examples of tumor antigens
- classify tumor antigens by cancer type
- list bacterial antigens
- list viral antigens
- list fungal antigens
- list parasitic antigens
- list mycobacterial antigens
- describe allergens
- list natural, animal, and plant allergens
- describe enzymes for bioremediation
- list enzymes for bioremediation
- describe detectable labels
- list radioisotopes
- describe fluorophores
- list organic fluorophores
- describe enzymes as detectable labels
- describe biotin and avidin as detectable labels
- describe paramagnetic agents and chemotherapeutic agents
- list immunomodulators and additional products

### Methods of Treatment

- introduce particle constructs for treatment
- select agent of interest for treatment
- administer therapeutically effective amount to subject
- define subjects, including humans and animals
- diagnose conditions using laboratory tests
- take medical history and conduct physical examination
- treat subjects with tumors or at risk of developing tumors
- treat subjects with infections or at risk of contracting infections
- treat subjects with autoimmune disorders
- treat subjects with allergies or asthma
- administer particle constructs with tumor antigens
- administer particle constructs with chemotherapeutic agents
- administer particle constructs with immunostimulatory molecules
- treat subjects with hematological tumors
- treat subjects with solid tumors
- treat subjects with bacterial, viral, fungal, or parasitic infections
- administer particle constructs with adjuvants
- determine therapeutically effective amount based on various factors
- describe mineral salts as adjuvants
- describe outer membrane proteins as Th1 biasing adjuvants
- describe proteosomes as mucosal adjuvants
- describe combinations of adjuvants
- describe adjuvant formulations with mineral salts
- describe adjuvant formulations with oil and water emulsions
- describe effective amounts for tumor treatment
- describe effective amounts for symptom relief
- describe effective amounts for imaging
- describe administration methods for particle constructs
- describe single and multiple administrations
- describe dosage regimens
- describe immunization regimens
- describe prime-boost protocols
- describe pharmaceutical compositions
- describe administration routes
- describe formulation for oral administration
- describe kits for particle constructs

### Environmental Use

- define bioremediation enzymes
- application of enzymes to environmental pollutants
- methods for degrading environmental pollutants
- embodiments of environmental mediums and contaminants

## EXAMPLES

- introduce spore coat of Bacillus and its complexity

### Example 1

- describe strain construction
- describe protein purification and labeling
- describe SSLB preparation
- describe SSHEL particle construction
- describe epifluorescence microscopy
- describe scanning electron microscopy
- describe surface modification of SSHEL particles

### Example 2

- motivate SpoVM is necessary and sufficient to anchor SpoIVA
- describe SpoVM-coated SSLBs and SpoIVAAF488 adsorption
- compare SpoIVAAF488 adsorption with and without SpoVM
- conclude SpoVM is sufficient for anchoring and uniformly distributing SpoIVA

### Example 3

- motivate stable association of SpoIVA with the forespore requires ATP
- describe SpoIVAAF488 adsorption onto SSLBs with and without ATP
- conclude ATP is required for the irreversible association of SpoIVA on the membrane

### Example 4

- motivate ultrastructure of SSHEL particles
- describe SEM analysis of SSHEL particles

### Example 5

- motivate covalent decoration of SSHELs
- describe limitations of prior art
- demonstrate covalent linking of molecules to SSHELs
- discuss potential applications of SSHEL particles

### Example 6

- describe mucosal administration of SSHEL particles in an in vivo model

